The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung Disease
CHEST · 2024-09 · 166 (3) · 517-527
DOI: 10.1016/j.chest.2024.02.043 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift CHEST, 2024-09. Verfasst von Sabina A Guler und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;…. Hauptthemen laut MEDLINE: Frailty, Lung Diseases, Interstitial. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND: Previous studies have shown the importance of frailty in patients with fibrotic interstitial lung disease (ILD). RESEARCH QUESTION: Is the Clinical Frailty Scale (CFS) a valid tool to improve risk stratification in patients with fibrotic ILD? STUDY DESIGN AND METHODS: Patients with fibrotic ILD were included from the prospective multicenter Canadian Registry for Pulmonary Fibrosis. The CFS was assessed using available information from initial ILD clinic visits. Patients were stratified into fit (CFS score 1-3), vulnerable (CFS score 4), and frail (CFS score 5-9) subgroups. Cox proportional hazards and logistic regression models with mixed effects were used to estimate time to death or lung transplantation. A derivation and validation cohort was used to establish prognostic performance. Trajectories of functional tests were compared using joint models. RESULTS: Of the 1,587 patients with fibrotic ILD, 858 (54%) were fit, 400 (25%) were vulnerable, and 329 (21%) were frail. Frailty was a risk factor for early mortality (hazard ratio, 5.58; 95% CI, 3.64-5.76, P < .001) in the entire cohort, in individual ILD diagnoses, and after adjustment for potential confounders. Adding frailty to established risk prediction parameters improved the prognostic performance in derivation and validation cohorts. Patients in the frail subgroup had larger annual declines in FVC % predicted than patients in the fit subgroup (-2.32; 95% CI, -3.39 to -1.17 vs -1.55; 95% CI, -2.04 to -1.15, respectively; P = .02). INTERPRETATION: The simple and practical CFS is associated with pulmonary and physical function decline in patients with fibrotic ILD and provides additional prognostic accuracy in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Lung Precision Medicine (LPM), Department for BioMedical Research (DB…
- Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
- Department of Medicine, McMaster University, Hamilton, ON, Canada.
- Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
- Department of Medicine, University of Toronto, Toronto, ON, Canada.
- Department of Medicine, University of Calgary, Calgary, AB, Canada.
Zitieren
APA
Guler, S. A., Marinescu, D. C., Cox, G., Durand, C., Fisher, J. H., Grant-Orser, A., Goobie, G. C., Hambly, N., Johannson, K. A., Khalil, N., Kolb, M., Lok, S., MacIsaac, S., Manganas, H., Marcoux, V., Morisset, J., Scallan, C., Shapera, S., Sun, K., …, & Wong, A. W. (2024). The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung Disease. CHEST, 166(3), 517-527. https://doi.org/10.1016/j.chest.2024.02.043
Vancouver
Guler SA, Marinescu DC, Cox G, Durand C, Fisher JH, Grant-Orser A, et al. The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung Disease. CHEST. 2024;166(3):517-527. doi:10.1016/j.chest.2024.02.043
BibTeX
@article{Guler2024,
author = {Guler, Sabina A and Marinescu, Daniel-Costin and Cox, Gerard and Durand, Celine and Fisher, Jolene H and Grant-Orser, Amanda and Goobie, Gillian C and Hambly, Nathan and Johannson, Kerri A and Khalil, Nasreen and Kolb, Martin and Lok, Stacey and MacIsaac, Sarah and Manganas, Helene and Marcoux, Veronica and Morisset, Julie and Scallan, Ciaran and Shapera, Shane and Sun, Kelly and Zheng, Boyang and Ryerson, Christopher J and Wong, Alyson W},
title = {The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung Disease},
journal = {CHEST},
year = {2024},
volume = {166},
number = {3},
pages = {517--527},
doi = {10.1016/j.chest.2024.02.043}
}
EUVIMED